Bailard’s Atea Pharmaceuticals AVIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-24,400
Closed -$218K 728
2021
Q4
$218K Buy
+24,400
New +$218K 0.01% 662